Metastable crystallization improves pore size control and stability in metal-organic framework membranes for pharmaceutical applications.
Structurally ordered metal-organic framework (MOF) membranes hold great promise for selective molecular separations in chemical and pharmaceutical industries due to their precise pore size control and strong stability in organic solvents. However, the high surface energy of MOF nanodispersions complicates their assembly, leading to nonselective grain boundaries and poor processability, which hinder practical application. Here, we present a metastable phase crystallization (MPC) strategy that leverages nonclassical crystallization pathways to fabricate MOF membranes with high precision and structural uniformity. This approach combines sol-gel coating with vapor-phase reactions and ligand insertion, enabling the preparation of membranes with finely tunable pore sizes. Al-MOF membranes prepared by MPC exhibit excellent solvent permeance and solute retention, together with enhanced stability under elevated pressures and long-term operation. By tailoring pore sizes through ligand incorporation, molecular separation performance is further improved. A 10-tube tubular MOF membrane module with an effective area of 230 square centimeters highlights the potential scalability of this approach for industrial separations.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: